About Me:

Best Hospital in Indore


Tue, Thu & Sat

(09:00 AM to 05:00 PM)

Dr. Rajesh Patidar

Consultant Medical Oncologist   

Professional Summary  

Dr.Rajesh Patidar has completed his Bachelors of Medicine and Bachelors of Surgery (MBBS) from Madras medical college, Chennai in year 2010 and MD in General Medicine from Lady hardinge medical college, Delhi in year 2014.He then completed his Doctorate of Medicine (DM) in Medical Oncology from Kidwai Cancer Institute, Bengaluru in year 2018.

Technical Skills  

  1. Treatment and counselling of patients receiving systemic therapies for solid and haematological malignancies: Chemotherapy, Hormonal therapies, biological therapies, Targeted Therapy, Immunotherapy.  
  2. Prescribe and administer Chemotherapy, biological therapy, Immunotherapy, Targeted therapy.  
  3. Diagnose and manage side effects of anti-cancer treatments.  
  4. Perform central line insertion, PICC line insertion, Bone Marrow aspiration and biopsy, lumbar puncture and intrathecal drug administration.  
  5. Perform image-guided tru-cut biopsies, FNAC’s, pleural and peritoneal paracentesis.  
  6. Diagnose and manage medical and oncological emergencies.
  7. Autologous stem-cell transplant for Hodgkin’s lymphoma, Non-Hodgkin’s lymphoma, Multiple Myeloma. 
  8. Induction and consolidation chemotherapies for ALL/AML.  
  9. Management of malignancies in patients with HIV/AIDS.  
  10. Participate and contribute in a Multidisciplinary clinic. 

Scientific And Medical Societies Membership

A. Indian Society of Medical and Pediatric Oncology 

B. American Society of Clinical Oncology 




Conference Title

Awards and  


First prize

Innovation in Oncology-Lung cancer edition,  Indian Society of Oncology (ISO), April 2017

Second prize

37th ICON (Indian Cooperative Oncology  Network) Quiz for Best PG Institute , Delhi  September 2017

Third prize

Indian Society of Medical and Pediatric Oncology Torrent Young Scholar Award, 2018- First Prize

Sixth Position

Cancer Institute Orientation Program (COPE),  Cancer Institute (WIA) Adyar, Chennai 2018

Work Experience 

  1. Junior Residency (During MD training, General medicine, at Lady Hardinge Medical college Delhi, Indore, May 2011-May 2014) 

a. Significant experience in diagnosing illnesses, prescribing and administering appropriate treatment/medications for various ailments or diseases.

b. Experience in handling in/out Patients and managing ICU, ICCU & monitoring the patients. 

c. Proficiency in patient counselling and training subordinates in protocol-based management of cases.

d. Teaching experience to undergraduate (MBBS) students.  

2. Senior Residency in Department of Clinical Hematology at Safadarjung Hospital, Delhi (August 2014 – June 2015)  

a. Management of patients with Leukemia, Lymphoma, Myeloma and MDS.

b. Management of patients with benign haematological disorder like  ITP, Anaemia and Hemophilia. 

3. DM training (Medical Oncology) at Kidwai Cancer Institute (earlier known as Kidwai Memorial Institute of Oncology), Bengaluru, August 2015- August 2018)  

a. Out-patient and in-patient care of cancer patients.

b. Workup and management of patients with various solid tumors. 

c. Workup and management of leukemia and lymphoma patients. 

d. Prescribing and supervising chemotherapy administration.

e. Providing Expert consultation to other Departments.

f. Teaching experience

i. Nursing: Chemotherapy preparation and administration. 

ii. Medicine Graduates: Principles of oncology, oncological emergencies, Approach to a patient with generalized lymphadenopathy, Management of hematological malignancies.

Conferences and Seminars 

A. Intradepartmental (Department of medical oncology) 

a) Cancer Immunotherapy 

b) HDAC Inhibitors and Demethylating agents 

c) Cancer Screening 

d) Anti her2 therapy 

e) PET CT in Oncology 

f) Management of Gastrointestinal tumor

B. Interdepartmental (Multidisciplinary meeting)

a) Role of chemotherapy and targeted therapy in carcinoma oesophagus.  


i. A study of vit-d (25 hydroxy cholecalciferol) levels in patients of acute ischemic stroke. (Dissertation during M.D.) . 

ii. A Prospective study to evaluate Pathological, Radiological response, Toxicity profile, and Pharmacoeconomics of IAP and AP Regimens in localized high – grade osteosarcoma as Neoadjuvant chemotherapy (Dissertation during D.M.) 

iii. Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma. (Project). 

iv. Assessment and comparison of CISNE model versus MASCC model in clinically stable febrile neutropenia patients. Kidwai Cancer Institute. (Project).

v. CXCR-4 expression and its correlation with Clinical- Biological characteristics in patients with Acute Myeloid Leukemia. Kidwai Cancer Institute. (Project).

vi. A Prospective Study to Determine the Clinical Characteristics and Response to Treatment in Double Expressor DLBCL Among All DLBCL Patients in a Tertiary Care Hospital in South India, Kidwai Cancer Institute.(Project).

vii. A study of recurrent /metastatic breast cancer in relation to their primary subtype, pattern of recurrence and the discordance rate of ER, PR and HER2.Kidwai Cancer Institute. (Project).


A. Original Articles

  1. Pattern of bone marrow involvement by solid tumors: Experience from a tertiary care center from South India. AH Rudresha, Rajesh Patidar, Kuntegowdanahalli C Lakshmaiah, K Govind Babu, Dasappa Lokanatha, Linu Abraham Jacob, MC Suresh Babu, NR Namrata, N Lokesh Kadabur, LK Rajeev, Abhishek Anand, Vikas Asati. Indian J Med Paediatr Oncol 2018;XX:XX-XX. DOI: 10.4103/ijmpo.ijmpo_170_17(Corresponding author: Rajesh patidar) 
  2. Metastatic Synovial Sarcoma: Experience from a Tertiary Care Center from India. K Govind Babu, Rajesh Patidar, C Lakshmaiah Kuntegowdanahalli, Lokanatha Dasappa, Linu Abraham Jacob, Suresh Babu, AH Rudresha, Lokesh N Kadabur, LK Rajeev, Deepak Koppaka, Vikas Asati. DOI: 10.4103/ijmpo.ijmpo_237_17(Corresponding author: Rajesh Patidar) 
  3. Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B‐cell lymphoma. Lakshmaiah, K. C., Asati, V. , Babu, K. G., Lokanath, D. , Jacob, L. A., Babu, M. C., Lokesh, K. N., Rajeev, L. K., Rudresh, A. H., Saldanha, S., Koppaka, D. , Patidar, R. and Premalata, C. S. (2018 Eur J Haematol. DOI: 10.1111/ejh.13068 
  4. IT-Cell Prolymphocytic Leukemia: An Experience from a Tertiary Cancer Centre in South India Babu, S., Anand, A., Lakshmaiah, K.C., Lokanatha, D., Jacob, L.A., Madhumathi, D.S., Lokesh, K.N., Rudresha, A.H., Rajeev, L.K. and Patidar, R., 2018.. International Journal of Hematology-Oncology and Stem Cell Research, 12(2), pp.132-135. 
  5. Genito-Urinary Malignancies In Patients With Disorders Of Sexual Development: An Experience From A Regional Cancer Center Haleshappa RA, Koppaka D, Thanky AH, Padma M, Amirtham U, Kuntegowdanahalli LC, Kanakasetty GB, Dasappa L, Jacob LA, Mc Babu S, Lokesh KN, Rajeev L K, Rajesh Patidar. 
  6. Clinical profile and treatment outcomes of metastatic neuroendocrine carcinoma: A single institution experience K. N. Lokesh, Abhishek Anand, K. C. Lakshmaiah, K. Govind Babu, Dasappa Lokanatha, Linu Abraham Jacob, M. C. Suresh Babu, A. H. Rudresha, L. K. Rajeev, Smitha C. Saldanha, G. V. Giri, Dipti Panwar, Deepak Koppaka, Rajesh Patidar DOI: 10.4103/sajc.sajc_176_17.  

B. Abstract 

  1. Role of prephase treatment prior to definitive chemotherapy in diffuse large B-cell lymphoma (DLBCL) A. Rudresha, V. Asati, L.C. Kuntegowdanahalli, G. Babu, D. Lokanatha, L.A. Jacob, S. Babu, C.S. Premalata, L. Rajeev, K.N. Lokesh, S.C. Saldanha, R. Patidar; 1012P. Annals of Oncology, Volume 28, Issue suppl_5, 1 September 2017, mdx373.018.

C. Case Report 

  1. A rare case of primary synovial sarcoma of lung. Rajeev LK, Patidar R, Babu G, Babu MS, Lokesh KN, Okaly GV. Lung India: official organ of Indian Chest Society. 2017 Nov;34(6):545.
  2. Extranodal NK/T-cell lymphoma of the nasal type with predominant T-cell markers: A rare subtype of rare disease entity. Varshney AN, Patidar R, Malhotra M, Behera M, Nagar M, Kataria SP International Journal of Medicine and Public Health. 2015;5(4).